AER001
AER001 Uses, Dosage, Side Effects, Food Interaction and all others data.
AER001, an IL4/13 receptor antagonist for severe asthma and eczema currently in Phase 2 studies.
Trade Name | AER001 |
Generic | AER001 |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in asthma.
Innovators Monograph
You find simplified version here AER001